Multicenter evaluation of the analytical and clinical performance of the Bayer Immuno 1™ HER-2/neu Assay.

被引：0
|
作者：
Neaman, IE
Goldblatt, JL
Cook, GB
Bruzek, D
Smith, C
Morris, DL
Schwartz, MK
Chan, DW
Allard, WJ
机构：
[1] Bayer Corp, Tarrytown, NY USA
[2] Johns Hopkins Univ Hosp, Div Clin Chem, Baltimore, MD 21287 USA
[3] Mem Sloan Kettering Canc Ctr, Clin Labs, New York, NY 10021 USA
来源：
CLINICAL CHEMISTRY | 2000年 / 46卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
626
引用
收藏
页码：A162 / A162
页数：1
相关论文
共 50 条
  • [31] Analytical and clinical evaluation of the Bayer ADVIA Centaur® homocysteine assay
    Tewari, PC
    Zhang, B
    Bluestein, BI
    CLINICA CHIMICA ACTA, 2004, 342 (1-2) : 171 - 178
  • [32] Preliminary analytical and clinical evaluation of the IMMULITE 2500 NTProBNP assay.
    Gaze, D. C.
    Galasko, G. I.
    Senior, R.
    Lahiri, A.
    Collinson, P. O.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A129 - A129
  • [33] Evaluation of the estradiol assay on the Bayer TECHNICON IMMUNO 1 system(R).
    Levesque, A
    Letellier, M
    Dillon, PW
    Grant, A
    CLINICAL CHEMISTRY, 1996, 42 (06) : 570 - 570
  • [34] Evaluation of HER-2/neu status by fluorescent in situ hybridization (FISH) in a reflex model of HER-2/neu testing in a tertiary academic setting
    Cosar, EF
    Siziopikou, KP
    LABORATORY INVESTIGATION, 2003, 83 (01) : 26A - 26A
  • [35] Aneusomy 17 in breast cancer: Its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status
    Wang, SJ
    Saboorian, MH
    Frenkel, EP
    Haley, BB
    Siddiqui, MT
    Gokaslan, S
    Hynan, L
    Ashfaq, R
    MODERN PATHOLOGY, 2002, 15 (02) : 137 - 145
  • [36] Evaluation of HER-2/neu status by fluorescent in situ hybridization (FISH) in a reflex model of HER-2/neu testing in a tertiary academic setting
    Cosar, EF
    Siziopikou, KP
    MODERN PATHOLOGY, 2003, 16 (01) : 26A - 26A
  • [37] Evaluation of Serum HER-2/neu Extracelluar Domain in Breast Cancer Patients: Correlation with Tissue HER-2/neu Status and Clinicopathological Factors
    Kang, Sun Hee
    Cho, Jihyoung
    Ha, Jung Sook
    Kwon, Sun Young
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 78 (05): : 271 - 276
  • [38] Evaluation of the progesterone assay on the Bayer TECHNICON IMMUNO 1 system(R).
    Levesque, A
    Letellier, M
    Dillon, PW
    Grant, A
    CLINICAL CHEMISTRY, 1996, 42 (06) : 571 - 571
  • [39] HER-2/neu gene copy quantified by real-time PCR and serum HER-2/neu by Elisa assay: comparison with fluorescence in situ hybridization and immunohistochemistry
    Tse, C.
    Brault, D.
    Gligorov, J.
    Antoine, M.
    Lelay, K.
    Lotz, J. P.
    EJC SUPPLEMENTS, 2004, 2 (03): : 171 - 171
  • [40] Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
    Díaz-Montes, TP
    Ji, HX
    Sehdev, AES
    Zahurak, ML
    Kurman, RJ
    Armstrong, DK
    Bristow, RE
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 139 - 144
12345